This is a non-core endpoint: only basic statistics are computed.
ILD medications: nintedanib
ILD_NINTENDANIB
No definition available.
Endpoint definition
↥392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
1 out of 7 registries used, show all original rules.
167
Check minimum number of events
167
Include endpoints None
167
Remove individuals based on genotype QC
163
Control definitions
Extra metadata
Not enough data for upset plot.
Or the full data table
Similar endpoints
↥List of similar endpoints to ILD medications: nintedanib based on the number of shared cases.
Broader endpoints:
- L01XE Protein kinase inhibitors
- ILD, hospital admissions 1, main diag only
- ILD, hospital admissions
- Interstitial lung disease
- Other interstitial pulmonary diseases
Narrower endpoints:
None
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 163 | 51 | 112 |
Unadjusted prevalence (%) | 0.04 | 0.02 | 0.07 |
Mean age at first event (years) | 71.07 | 70.76 | 71.21 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: ILD_NINTENDANIB – ILD medications: nintedanib
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after ILD medications: nintedanib
↥Endpoint not on priority list, no data to show.